Lucas GM - Search Results

1

Effect of Adopting the New Race-Free 2021 Chronic Kidney Disease Epidemiology Collaboration Estimated Glomerular Filtration Rate Creatinine Equation on Racial Differences in Kidney Disease Progression Among People With Human Immunodeficiency Virus: An Observational Study.

Muiru AN, Madden E, Scherzer R, Horberg MA, Silverberg MJ, Klein MB, Mayor AM, John Gill M, Napravnik S, Crane HM, Marconi VC, Koethe JR, Abraham AG, Althoff KN, Lucas GM, Moore RD, Shlipak MG, Estrella MM. Muiru AN, et al. Among authors: lucas gm. Clin Infect Dis. 2023 Feb 8;76(3):461-468. doi: 10.1093/cid/ciac731. Clin Infect Dis. 2023. PMID: 36069064 Free PMC article.

2

Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes.

Lucas GM, Lechtzin N, Puryear DW, Yau LL, Flexner CW, Moore RD. Lucas GM, et al. Clin Infect Dis. 1998 May;26(5):1127-33. doi: 10.1086/520311. Clin Infect Dis. 1998. PMID: 9597241

3

Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions.

Lucas GM, Chaisson RE, Moore RD. Lucas GM, et al. Ann Intern Med. 1999 Jul 20;131(2):81-7. doi: 10.7326/0003-4819-131-2-199907200-00002. Ann Intern Med. 1999. PMID: 10419445

4

Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection.

Lucas GM, Cheever LW, Chaisson RE, Moore RD. Lucas GM, et al. J Acquir Immune Defic Syndr. 2001 Jul 1;27(3):251-9. doi: 10.1097/00126334-200107010-00006. J Acquir Immune Defic Syndr. 2001. PMID: 11464144

5

Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenz.

Lucas GM, Chaisson RE, Moore RD. Lucas GM, et al. AIDS. 2001 Sep 7;15(13):1679-86. doi: 10.1097/00002030-200109070-00011. AIDS. 2001. PMID: 11546943

6

Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic.

Lucas GM, Gebo KA, Chaisson RE, Moore RD. Lucas GM, et al. AIDS. 2002 Mar 29;16(5):767-74. doi: 10.1097/00002030-200203290-00012. AIDS. 2002. PMID: 11964533

7

Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden?

Lucas GM, Flexner CW, Moore RD. Lucas GM, et al. AIDS Patient Care STDS. 2002 Nov;16(11):527-35. doi: 10.1089/108729102761041083. AIDS Patient Care STDS. 2002. PMID: 12513901 Review.

8

Survival in an urban HIV-1 clinic in the era of highly active antiretroviral therapy: a 5-year cohort study.

Lucas GM, Chaisson RE, Moore RD. Lucas GM, et al. J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):321-8. doi: 10.1097/00126334-200307010-00005. J Acquir Immune Defic Syndr. 2003. PMID: 12843742

9

Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study.

Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD. Lucas GM, et al. AIDS. 2004 Feb 20;18(3):541-6. doi: 10.1097/00002030-200402200-00022. AIDS. 2004. PMID: 15090808

10

Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study.

Lucas GM, Weidle PJ, Hader S, Moore RD. Lucas GM, et al. Clin Infect Dis. 2004 Jun 1;38 Suppl 5:S409-13. doi: 10.1086/421405. Clin Infect Dis. 2004. PMID: 15156431 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters